Patents Assigned to HUA MEDICINE (SHANGHAI) LIMITED
  • Patent number: 11666556
    Abstract: The present invention relates to a pharmaceutical combination, the pharmaceutical combination comprising a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic label thereof, a crystal form thereof, a hydrate, a solvate, a diastereomer or enantiomer, and a K-ATP channel blocker. The present invention further relates to a pharmaceutical composition, a fixed dose compound preparation, and a method for preparing the pharmaceutical composition and the fixed dose compound preparation as well as a use thereof.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: June 6, 2023
    Assignee: HUA MEDICINE (SHANGHAI) LIMITED
    Inventors: Li Chen, Yongguo Li, Gaosen Wang, Huisheng Gao